Mark D. Blostein

3755 Chemin De La Cote Ste Cat
Jewish General Hospital
Montreal, QC H3T1E2, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Extracellular RNA Induces Neutrophil Recruitment Via Toll-Like Receptor 3 During Venous Thrombosis After Vascular Injury.

Extracellular RNA Induces Neutrophil Recruitment Via Toll-Like Receptor 3 During Venous Thrombosis After Vascular Injury.

Journal: Journal of the American Heart Association

Published: July 19, 2024

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia.

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia.

Journal: Blood advances

Published: June 25, 2021

Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial.

Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial.

Journal: BMJ (Clinical research ed.)

Published: June 10, 2021

Performance of two clinical scales to assess quality of life in patients with post-thrombotic syndrome.

Performance of two clinical scales to assess quality of life in patients with post-thrombotic syndrome.

Journal: Journal of vascular surgery. Venous and lymphatic disorders

Published: October 14, 2020

Muscle Mass and Direct Oral Anticoagulant Activity in Older Adults With Atrial Fibrillation.

Muscle Mass and Direct Oral Anticoagulant Activity in Older Adults With Atrial Fibrillation.

Journal: Journal of the American Geriatrics Society

Published: July 26, 2020

Correction to: A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome.

Correction to: A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome.

Journal: Pilot and feasibility studies

Published: June 02, 2020

Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial.

Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial.

Journal: The Lancet. Haematology

Published: March 06, 2020

Venous limb gangrene and pulseless electrical activity (PEA) cardiac arrest during management of deep-vein thrombosis and progressive limb ischemic necrosis following vascular surgery.

Venous limb gangrene and pulseless electrical activity (PEA) cardiac arrest during management of deep-vein thrombosis and progressive limb ischemic necrosis following vascular surgery.

Journal: American journal of hematology

Published: January 24, 2020

Development of an INR for rivaroxaban monitoring using plasma samples from patients.

Development of an INR for rivaroxaban monitoring using plasma samples from patients.

Journal: Thrombosis research

Published: September 30, 2019

Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant.

Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant.

Journal: JAMA internal medicine

Published: August 06, 2019

A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome.

A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome.

Journal: Pilot and feasibility studies

Published: April 05, 2019

Peri-Operative Eltrombopag or Immune Globulin for Patients with Immune Thrombocytopaenia (The Bridging ITP Trial): Methods and Rationale.

Peri-Operative Eltrombopag or Immune Globulin for Patients with Immune Thrombocytopaenia (The Bridging ITP Trial): Methods and Rationale.

Journal: Thrombosis and haemostasis

Published: January 28, 2019

Showing 1-12 of 39

Last Updated: 09/26/2026